| MSD Merck Sharp & Dohme AG - Lyfnua, Filmtabletten | | 68065 | | 01 | | Lyfnua | | Filmtabletten | | R05DB29 | | Gefapixant | | 24.05.2022 | | |
| | Composition | | gefapixantum 45.00 mg ut gefapixanti citras, cellulosum microcristallinum, mannitolum, hypromellosum, crospovidonum, silica colloidalis anhydrica, natrii stearylis fumaras, magnesii stearas, Überzug: cera carnauba, hypromellosum, titanii dioxidum, triacetinum, E 172 (rubrum), pro compresso obducto corresp. natrium 0.794 mg. | | Packungsbestandteile | | Coated tablets | | | | Active Agent | Dose |
|---|
| Gefapixantum | 45 mg |
| | | | Inactive agents | | additional_information |
|---|
| (Rubrum) | | | | Cellulosum Microcristallinum | | | | Cera Carnauba | | Überzug | | Crospovidonum | | | | E 172 | | color. | | Hypromellosum | | | | Magnesii Stearas | | | | Mannitol | | | | Natrii Stearylis Fumaras | | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Titanium Dioxide | | | | Triacetinum | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | 56 | PR | PR | B | | Yes | | 003 | 196 | PR | PR | B | | Yes |
|
|
